Table 2 Vital signs and complications of 226 patients with COVID-19 in ICUs
From: Patients with COVID-19 in 19 ICUs in Wuhan, China: a cross-sectional study
Characteristics | All patients (n = 226) |
|---|---|
Heart rate (bpm) | 90 (76–103) |
 Heart rate > 125 | 9 (4.0%) |
Systolic blood pressure (mmHg) | 125 (110–137) |
 Systolic blood pressure < 90 | 2 (0.9%) |
Diastolic blood pressure (mmHg) | 72 (64–80) |
Respiratory rate (breaths per minute) | 22 (20–26) |
 Respiratory rate > 24 | 86 (38.1%) |
Saturation of pulse oxygen | 97 (95–99) |
 Saturation of pulse oxygen < 90% | 14 (6.2%) |
Temperature (°C) | 36.7 (36.4–37) |
 > 37.3 to ≤ 38 | 21 (9.3%) |
 > 38 | 24 (10.6%) |
SOFA score (n = 192) | 4 (2–8) |
ARDS | 161 (71.2%) |
 Mild ARDS | 35 (15.5%) |
 Moderate ARDS | 47 (20.8%) |
 Severe ARDS | 79 (35.0%) |
Shock | 36 (15.9%) |
 Septic shock | 33 (14.6%) |
 Cardiogenic shock | 2 (0.9%) |
 Septic combined cardiogenic shock | 1 (0.4%) |
Cardiac injury (hs-TnI > 28 ng/L or TnI > 0.3 ng/mL) | 61 (27.0%) |
Arrhythmia | 21 (9.3%) |
 Atrial fibrillation | 18 (8.0%) |
 Supraventricular tachycardia | 2 (0.9%) |
 Ventricular tachycardia | 1 (0.4%) |
Acute kidney injury by KDIGO criteria | 57 (25.2%) |
 Stage 1 | 23 (10.2%) |
 Stage 2 | 12 (5.3%) |
 Stage 3 | 22 (9.7) |
Hospital-acquired bacterial or fungal infection | 49 (21.7%) |
 Duration from the onset of symptom to the current study, days | 33 (27–37) |
 Duration from ICU admission to the current study, days | 13 (8–17.5) |
 Infectious foci | |
  Pulmonary | 45 (19.9%) |
  Pulmonary and bloodstream | 2 (0.9%) |
  Pulmonary and deep soft tissue | 1 (0.4%) |
  Urinary tract | 1 (0.4%) |
Pneumothorax | 1 (0.4%) |
Gastrointestinal hemorrhage | 7 (3.1%) |